Blood thinners for brain blood clot in Chinese patients
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests two blood thinner medicines, edoxaban and rivaroxaban, in Chinese patients with a blood clot in a brain vein (cerebral venous thrombosis). It aims to see if these medicines are safe and work well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with a blood clot in a brain vein within the last 4 weeks.
- Your doctor thinks you are suitable for treatment with edoxaban or rivaroxaban.
- You are not pregnant, breastfeeding, or planning to become pregnant.
- You do not have severe bleeding risk, kidney or liver problems, or other conditions that prevent using blood thinners.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a medication called batroxobin to standard blood thinners can help treat blood clots in the veins of the brain better than blood thinners alone. It is for people who have been diagnosed in the last month and are not at high risk for bleeding.
This trial tests whether taking blood-thinning pills (called DOACs) after initial treatment can safely treat blood clots in the veins of the brain. You may be able to join if you recently had this condition and start the pills within the first two weeks of treatment.
This study looks at how well certain blood thinners (NOACs and ticagrelor) work in Chinese patients and how they might affect bleeding risk. Researchers will measure drug levels and markers in your blood to try to make these medicines safer and more effective.
This study looks at people with cerebral venous thrombosis who were treated with blood thinners taken by mouth (or started within the first 30 days). It uses observational data to understand how these treatments are used and what outcomes may follow.
This trial tests a new oral blood thinner to prevent another bleeding episode in people with liver cirrhosis who have already had variceal bleeding and also have a clot in the portal vein. The goal is to see if it can safely reduce the risk of rebleeding.
This study tests different ways to use blood thinners after a minimally invasive heart valve repair procedure. It may help patients who need long-term blood thinning to prevent clots or stroke.
Hear when a new Cerebral Venous Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.